Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OXN vs Placebo in Chronic Low Back Pain
NCT01358526Phase 3Completed
- Sponsor
- Purdue Pharma
- Start
- May 2011
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oxycodone + naloxone in chronic low back pain (CLBP), sponsored by Purdue Pharma. Started May 2011; status: completed.
02
Drugs
oxycodone + naloxone
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT01358526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01358526.